Article Text

Download PDFPDF

5PSQ-035 Mass uniformity of hard capsules: royal Spanish pharmacopoeia vs United States pharmacopoeia
  1. S Prieto Román,
  2. N Barrueco Fernández,
  3. EA Álvaro Alonso,
  4. A Such Díaz,
  5. C Esteban Alba,
  6. L De Agustín SIERRA,
  7. B Montero Pastor,
  8. L López Guerra,
  9. A Santiago Pérez,
  10. L Pedraza Nieto,
  11. I Escobar Rodríguez
  1. Infanta Leonor University Hospital, Pharmacy Department, Madrid, Spain


Background and Importance Quality control (QC) is an important part of the quality assurance of the elaborating process in a Hospital-Pharmacy-Department (HPD).The mass uniformity is the most commonly procedure used for QC of hard-capsules.

Aim and Objectives Analyse comparatively the Royal-Spanish-Pharmacopoeia (RSP) hard-capsule mass uniformity method versus the United-States-Pharmacopoeia (USP).

Material and Methods The following parameters of each method were analysed: sample, average reference weight, percentage and acceptance requirements. Also, the elaborating process necessary to apply each method.

Finally, the elaboration of a batch of 100 hard-capsules of dexamethasone 40mg according to the HPD Standard-Operating-Procedure was taken as a reference. Then the elaborations were retrospectively reviewed from February-2020 to February-2021.

The QC had been carried out with the RSP-method and the USP-method was then applied. For this, the theoretical weight of a capsule was calculated taking the average weight of 5 empty capsules (0.0493g) as reference and the weight of the batch content (13.8g=dexamethasone (4g) + excipient (9.8g)) calculated in the compounding design being the acceptance interval 0.169–0.206g.

Results The RSP-method requires a sample of 20 capsules and uses their average weight as a reference, while the USP-method requires a sample of 5% or 10 capsules (whichever is less) and uses the theoretical weight of a capsule as a reference. The RSP-method admits a deviation of ± 10% or ± 7.5% depending on the average weight; and no >2 capsules can deviate from the limits and none more than double. The USP-method accepts a limit of ± 10% respect to the theoretical weight, and no capsule must deviate.

Regarding the compounding method, the RSP allows elaboration by volumetric filling according to the Spanish-National-Formulary (excipients weight is not required). However, the USP-method requires knowing the theoretical capsule weight, which implies weighing the excipients.

Since February-2020 to February-2021, 8 batches of dexamethasone 40mg were elaborated. They were accepted with the RFE-method. After applying the USP-method, none were rejected.

Conclusion and Relevance The USP-method is safer than the RSP-method because for the same acceptance interval ( ± 10%) it does not admit any deviation. It also requires knowing the weight of all the excipients. Therefore, it is capable of detecting errors in the elaboration that the RFE-method would not detect (as long as the error is >10% and the capsules are homogeneous).

Currently, the USP-method has been incorporated in the HPD as a reference of hard capsules QC, since it provides greater safety in their preparation.

Conflict of Interest No conflict of interest.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.